Kim Le

Kim Le

Auto-generated profile, based on publicly available information

Kim Le

Amgen, Inc., Thousand Oaks, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2018 in Biotechnology Progress
Verified
Journal Article
Open access
PDF file
KLKim Le
Kim Le
CTChristopher Tan
Christopher Tan
SGShivani Gupta
Shivani Gupta
TGTrupti Guhan
Trupti Guhan
HBHedieh Barkhordarian
Hedieh Barkhordarian
TMTrent Munro
Trent Munro
Generating a highly productive cell line is resource intensive and typically involves long timelines because of the need to screen large numbers of candidates in protein production studies. This has led to miniaturization and automation strategies to allow for reductions in resources and higher throughput. Current approaches rely on the use of standard cell culture vessels and bulky liquid handling equipment. New nanofludic technologies offer novel solutions to surpass these limits, further miniaturizing cell culture volumes (10 5 times smaller) by growing cells on custom nanofluidic chips. Berkeley Lights’ OptoElectro Positioning technology projects light patterns to activate photoconductors that gently repel cells to manipulate single cells on nanofluidic culturing chips. Using a fully integrated technology platform (Beacon), common cell culture tasks can be programmed through software, allowing maintenance and analysis of thousands of cell lines in parallel on a single chip. Here, we describe the ability to perform key cell line development work on the Beacon platform. We demonstrate that commercial production Chinese hamster ovary cell lines can be isolated, cultured, screened, and exported at high efficiency. We compare this process head to head with a FACS‐enabled microtiter plate‐based workflow and demonstrate generation of comparable clonal cell lines with reduced resources. © 2018 American Institute of Chemical Engineers Biotechnol. Prog ., 34:1438–1446, 2018

28 July 2021 in Biotechnology Progress
Verified
Journal Article
Open access
PDF file
JDJonathan Diep
Jonathan Diep
HLHuong Le
Huong Le
KLKim Le
Kim Le
EZEwelina Zasadzinska
Ewelina Zasadzinska
JTJasmine Tat
Jasmine Tat
JSJennitte Stevens
Jennitte Stevens
Cell line development (CLD) represents a critical, yet time‐consuming, step in the biomanufacturing process as significant resources are devoted to the scale‐up and screening of several hundreds to thousands of single‐cell clones. Typically, transfected pools are fully recovered from selection and characterized for growth, productivity, and product quality to identify the best pools suitable for single‐cell cloning (SCC) using limiting dilution or fluorescence‐activated cell sorting (FACS). Here we report the application of the Berkeley Lights Beacon Instrument (BLI) in an early SCC process to accelerate the CLD timeline. Transfected pools were single‐cell cloned when viabilities reached greater than 85% or during selection when viabilities were less than 30%. Clones isolated from these accelerated processes exhibited comparable growth, productivity, and product quality to those derived from a standard CLD process and fit into an existing manufacturing platform. With these approaches, up to a 30% reduction in the overall CLD timeline was achieved. Furthermore, early process‐derived clones demonstrated equivalent long‐term stability compared with standard process‐derived clones over 50 population doubling levels (PDLs). Taken together, the data supported early SCC on the BLI as an attractive approach to reducing the standard CLD timeline while still identifying clones with acceptable manufacturability.

24 July 2024 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
YYYu Yuan
Yu Yuan
TWTony Wang
Tony Wang
JSJordan Sims
Jordan Sims
KLKim Le
Kim Le
CUCenk Undey
Cenk Undey
EOErdal Oruklu
Erdal Oruklu